Loading...

The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma

RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cell Cycle
Main Authors: Li, Zhenqing, Xue, Qun, Xu, Jianxun, Zhang, Pengfei, Ding, Bo
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/
https://ncbi.nlm.nih.gov/pubmed/33064970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!